BJU International

Article	Citations
‘Case of the Month’ from Thomas Jefferson University, Philadelphia, PA, USA: a large renal pseudoaneurysm masquerading as advanced renal cell carcinoma	78
Association between total prostate‐specific antigen (tPSA), free/tPSA, and prostate cancer mortality	77
Is Artificial Intelligence Ready for “Primetime” in Urology?	75
Journal information	64
Surveillance of non‐muscle‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis	59
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer	53
Editorial Board	52
April's reviewers of the month	51
	48
Age‐related PSA testing for prostate cancer: NICE recommendation 1.6.3	47
Editorial Board	47
Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?	42
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension	41
Lower urinary tract electrical sensory assessment: a systematic review and meta‐analysis	41
Eve's and Adam's rib for prostate cancer screening	40
Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial	39
ChatGPT – Integrity: Artificial Intelligence Misuse in Medical Writing	37
Building a research profile during residency	36
The LANDMARK project: providing summaries of key papers that have shaped urological practice	36
	35
The impact of post‐nephroureterectomy surgically induced chronic kidney disease on survival outcomes	33
Learning curve analysis of single‐port robot‐assisted extraperitoneal prostatectomy using the cumulative sum (CUSUM) method	32
	31
Comparison of the effects of extrinsic compression on the drainage performance of three ureteric stents	31
Impact of the COVID‐19 pandemic on the burnout rates of graduating Canadian Urology residents	30

Retzius‐sparing versus standard robot‐assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer	30
The European Association of Urology talent incubator: bridging competencies for holistic urological care	29
Author Index	28
Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography (PSMA‐PET) and magnetic resonance imaging (MRI) to improve diagnosis of pros	27
A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant?	26
Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit	26
April's reviewers of the month	26
Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?	26
Prolonged ischaemia during partial nephrectomy: impact of warm vs cold	25
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?	25
Recent key papers in prostate cancer	24
NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome	24
MRI, Prostate cancer diagnosis, and Artificial Intelligence; What are the implications?	24
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial	24
Sustainability in urology – are we doing enough?	23
September's reviewers of the month	23
How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway	23
The erector spinae plane block can facilitate outpatient stone surgery by reducing breakthrough pain	22
Progress in the management of stone disease	22
	22
Table of Contents	22
	22
Can exercise increase natural killer cell infiltration of the prostate?	22
Editorial Board	22
Thulium fibre laser lithotripsy, the new standard?	22
The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy	21
Comparison of serum and plasma microRNA expression levels in patients with germ cell tumours	21
Why prompting matters: achieving clinically accurate and consistent responses with Chat GPT	20
	20
The rapid assessment for prostate imaging and diagnosis (RAPID) prostate cancer diagnostic pathway	20
Quality‐of‐life outcomes of the ROBOtic‐assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial	20
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐less’ Randomised Trial Protocol	19
Incidence, risk factors, and temporal trends of penile cancer: a global population‐based study	19
Corrigendum	18
‘Igloo’ technique for robot‐assisted radical prostatectomy – maximum nerve sparing for early recovery of continence and sexual function	18
Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients	18
Analgesic efficacy of rectus sheath catheter is non‐inferior to thoracic epidural catheter	18
The effect of different assays on prostate‐specific antigen testing	18
International Alliance of Urolithiasis guideline on retrograde intrarenal surgery	17
Caval thrombectomy a urological leap into the unknown – a call for action	17
Sepsis prevalence and associated hospital admission and mortality after ureteroscopy in employed adults	17
Can only AI can save us from the burden of administration?	17
Blue vs white light for transurethral resection of non‐muscle‐invasive bladder cancer: an abridged Cochrane Review	17
Ureterorenoscopy during normothermic machine perfusion: effect of varying renal pelvis pressure	17
Is Gleason 6 cancer? The answer is more than just a ‘name’	17
A novel flexible vacuum‐assisted ureteric access sheath in retrograde intrarenal surgery	17
Opportunistic prostate‐specific antigen testing in Norwegian men: a public health challenge	17
Should patients with non‐muscle‐invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette–Guérin?	17
Journal information	16
TikTok and prostate cancer: misinformation and quality of information using validated questionnaires	16

Development of an optically transparent kidney model for laser lithotripsy research	16
Repeat MRI during active surveillance: natural history of prostatic lesions and upgrading rates	16
Editorial Board	16
In vivo ureteroscopic intrarenal pressures and clinical outcomes: a multi‐institutional analysis of 120 consecutive patients	16
Inhibition of phosphodiesterases 1 and 4 prevents myofibroblast transformation in Peyronie's disease	16
Pre‐versus postnatal presentation of posterior urethral valves: a multi‐institutional experience	16
Definitive local therapy for T4 prostate cancer associated with improved local control and survival	16
Issue Information	16
Urologist underutilisation of androgen receptor pathway inhibitors for metastatic hormone‐sensitive prostate cancer	16
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor	16
Editorial Board	15
High prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI‐RADS score 4 or 5 confers a high probability of	15
	15
Research Highlights	15
Editorial Board	15
Potential safety concerns in use of the artificial intelligence chatbot ‘ChatGPT’ for perioperative patient communication	15
Clinical presentation of bacille Calmette–Guérin (BCG) infections after BCG instillation therapy	15
	15
Bladder irrigation with tap water to reduce antibiotic use for urinary tract infections in catheter users	15
Journal information	15
Issue Information	15
Non‐infectious adverse events of transperineal prostate biopsies performed under local anaesthesia	14
Response to ‘Endpoint and control group in prostate cancer screening research: public health basics’	14
Renal cell carcinoma and tumour thrombus: devil is in the details of the technique not in the surgical approach	14
The importance of the urologist in male oncology fertility preservation	14
‘Case of the Month’ from the First Hospital of Sanming, Fujian Medical University, China: management of a renal haematoma with pyelonephritis and necrotising fasciitis	14
Case of the Month from UCSD, San Diego, USA: Treatment of giant dystrophic prostatic calcification using MOSES holmium laser	14
Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer	14
Vascular closure devices in living‐donor nephrectomy: a much‐needed systematic review and meta‐analysis focusing on safety	14
Functional outcomes of robot‐assisted partial nephrectomy in patients with a solitary kidney	13
Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours	13
Re‐defining the interpretation of 24‐h urine studies for stone formers	13
Acute Urinary Retention and Cancer; Is It All About the Prostate?	13
Key ingredients for running a randomised controlled trial in a surgical day unit	13
Cystectomy and lymphadenectomy – we now node how far to go!	13
Single‐port robot‐assisted nephroureterectomy via a supine anterior approach: step‐by‐step technique	13
Emergency department visits for radiation cystitis among patients with a prostate cancer history	12
Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable?	12
Clinicopathological predictors of finding additional inguinal lymph node metastases in penile cancer patients after positive dynamic sentinel node biopsy: a European multicentre evaluation	12
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE‐IMMUNO study	12
Table of Contents	12
Reversing the effects of androgen‐deprivation therapy in men with metastatic castration‐resistant prostate cancer	12
Outcomes after laser enucleation of the prostate with and without significant storage symptoms	12
Editorial Board	12
Neural monitoring of central responses to lower urinary tract function	12
Stone volume instead of maximum stone diameter: results from an international survey	12
Update from the Canadian Urological Association	12
Table of Contents	12
Issue Information	12
Global Urology, Urolink, and the BJUI	12
Perspectives on technology: Single‐use catheters – evidence and environmental impact	11
Recommendation on the use of protective eyewear in endourological laser procedures	11
Prognostic importance of concomitant non‐regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer	11
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function	11
Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta‐analysis	11
A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer	11
Surgical cystectomy training using human cadavers embalmed using Thiel's method: a pilot study	11
There is more to disposable endoscopes than whether they work…	11
Recovery and immune function after low pressure pneumoperitoneum during robot‐assisted radical prostatectomy: a randomised controlled trial	11
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging	11
Oncological outcomes after attempted nerve‐sparing radical prostatectomy (NSRP) in patients with high‐risk prostate cancer are comparable to standard non‐NSRP: a longitudinal long‐term propensity‐matc	11
Female non‐obstetric urogenital fistula repair: long‐term patient‐reported outcomes and a scoping literature review	11
A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy	11
Clinical implementation of pre‐biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer	11
Use of a microdebrider for epithelial excision during vaginectomy/colpocleisis in patients undergoing metoidioplasty	11
F‐SHARP: a Phase I/II trial of focal salvage high‐dose‐rate brachytherapy for Radiorecurrent prostate cancer	11
Learning curve for fusion magnetic resonance imaging targeted prostate biopsy and three‐dimensional transrectal ultrasonography segmentation	11
Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset	10
Google infodemiology and temporal trends in benign prostatic hyperplasia surgery in Australia	10
Impact of the SARS‐CoV‐2 virus on male reproductive health	10
Reduced‐dose bacillus Calmette‐Guérin (BCG) in an era of BCG shortage: real‐world experience from a tertiary cancer centre	10
A TREXIT Catalyst: an updated review of NHS England prostate biopsy data during COVID‐19	10
Editorial Board	10
Big trials in prostate cancer | predicting drug response in bladder cancer | immune checkpoint inhibitors for urothelial carcinoma | hydrochlorothiazide in the prevention of kidney stone recurrence	10
Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta‐analysis	10
Prognostic value of programmed death ligand‐1 and programmed death‐1 expression in patients with upper tract urothelial carcinoma	10
Positive surgical margin and oncological outcomes after robot‐assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups	10
A novel two‐stage approach to the treatment of renal cell carcinoma with intra‐cardiac tumour extension and Budd–Chiari syndrome	10
Editorial Board	10
	10

Editorial Board	10
First‐line programmed death receptor‐1 (PD‐1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum‐based chemotherapy, for stage IV penile cance	10
The challenges of conducting a surgical trial—reflections on the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial	10
Urine DNA for monitoring chemoradiotherapy response in muscle‐invasive bladder cancer: a pilot study	10
Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder	10
Editorial Board	10
Outcomes of robot‐assisted urinary sphincter implantation for male neurogenic urinary incontinence	9
Robot‐assisted single‐port transvesical enucleation of the prostate: step‐by‐step technique and early single‐centre experience	9
Response to Daungsupawong and Wiwanitkit: RE: The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers	9
A randomized controlled trial investigating rectus sheath catheters following radical cystectomy	9
A comment on: ‘Prevalence of urolithiasis in China: a systematic review and meta‐analysis’	9
Real‐world outcomes for high‐risk non‐muscle‐invasive bladder cancer: screened patients for the BRAVO trial	9
Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer	9
June's reviewers of the month	9
Added value of randomised biopsy to multiparametric magnetic resonance imaging‐targeted biopsy of the prostate in a contemporary cohort	9
Genomic profile – a possible diagnostic and prognostic marker in upper tract urothelial carcinoma	9
Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade	9
August's reviewers of the month	9
January’s reviewers of the month	9
Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer	9
Immunotherapy‐based neoadjuvant treatment and complication rates after radical cystectomy	9
Predicting early outcomes in patients with intermediate‐ and high‐risk prostate cancer using prostate‐specific membrane antigen positron emission tomography and magnetic resonance imaging	9
The first step in shared decision‐making for prostate cancer screening	9
A randomised trial comparing transurethral to percutaneous cystolithotripsy in boys	9
Issue Information	8
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer	8
Keith Kirkland Presentation	8
Intravenously engrafted human multilineage‐differentiating stress‐enduring (Muse) cells rescue erectile function after rat cavernous nerve injury	8
Low‐ versus standard‐ pneumoperitoneum in patients undergoing robot‐assisted radical prostatectomy: a randomised, triple‐blinded study	8
Efficacy of indocyanine green fluorescence‐guided inguinal lymph node dissection for penile cancer: a randomised trial	8
Case of the Month from Duke University Medical Centre: a complete renal staghorn stone	8
Concurrent Session Presentations	8
Journal information	8
Journal information	8
Villis Marshall Presentation	8
Do not treat Bill Gates for prostate cancer! Algorithmic bias and causality in medical prediction	8
	8
Is solo indocyanine green‐guided lymphadenectomy a feasible alternative to standard pelvic lymph node dissection?	8
Journal information	8
The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer – a multicentre observational study	8
Long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancer	8
Table of Contents	8
Bladder‐centric benign prostatic hyperplasia management post‐laser enucleation of the prostate	8
Is analgesic efficacy of rectus sheath catheter actually non‐inferior to thoracic epidural catheter?	8
Molecular margin status after radical prostatectomy using glutathione S‐transferase P1 (GSTP1) promoter hypermethylation	8
Working in the Time of a Pandemic – an Australian experience from Junior Doctors and YURO	8
Outcomes of the RAFT trial: robotic surgery after focal therapy	8
Risk stratification in men with a negative prostate biopsy: an interim analysis of a prospective cohort study	7
Use of bulbospongiosus muscle for repair of traumatic posterior urethral stenosis combined with urethrorectal fistulas	7
	7
Technetium‐99 m‐sestamibi single‐photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses	7
Abstract	7
Response to the letter by Kleebayoon et al. Re: Sui et al. ‘Re‐defining the interpretation of 24‐h urine studies for stone formers’	7
Table of Contents	7
An observational study of volume–outcome effects for robot‐assisted radical prostatectomy in England	7
Journal information	7
	7
Confocal laser microscopy for assessment of surgical margins during radical prostatectomy	7
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time	7
Uretero‐enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot‐assisted radical cystectomy	7
Case of the Month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses	7
Recovery of iatrogenic erectile dysfunction with somatic‐to‐autonomic sural nerve graft	7
Accuracy of MRI in detecting seminal vesicle invasion in prostate cancer: a systematic review and meta‐analysis	7
Telomerase reverse transcriptase mutation and the p53 pathway in T1 urinary bladder cancer	7
Risk of severe late toxicity after radiotherapy following radical prostatectomy – a nationwide study	7
	7
Post‐prostatectomy anastomotic stenosis: systematic review and meta‐analysis of endoscopic treatment	7
Novel bioabsorbable, low‐dose rate brachytherapy device (CivaSheet®) with radical prostatectomy and adjuvant external beam radiation for the management of prostate cancer	7
Prognostic impact of histological discordance between transurethral resection and radical cystectomy	7
Unravelling the evolution of medical scientific publishing to hold the promise of science for better patient care	7
Recovery of health‐related quality of life in patients undergoing robot‐assisted radical cystectomy with intracorporeal diversion	7
Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy	7
Reply to Huseyin Besiroglu's Letter to the Editor regarding the article ‘Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?’	7
Issue Information	7
Addition of neoadjuvant chemotherapy to a ‘quadrifecta’ composite in radical cystectomy	7
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics	6
Three‐dimensional virtual reconstruction guides robot‐assisted partial nephrectomy in a horseshoe kidney	6
Response to Takahashi	6
Voiding and renal function 10 years after radical cystectomy and orthotopic neobladder in women	6
Preoperative prediction of high‐risk lymph nodes in penile cancer: Graafland criteria vs radiomics	6
Issue Information	6
Versius robotic surgical system: case series of 18 robot‐assisted radical prostatectomies	6
Electronic medical records – a disappointing mirage for clinicians and research	6
Deep learning approach to predict lymph node metastasis directly from primary tumour histology in prostate cancer	6
Positive surgical margins in partial nephrectomy: a collaborative effort to maintain surgical quality	6
EndoSheath use in flexible cystoscopy: a prospective evaluation of >1000 cases	6
‘Case of the Month’ from Zhongnan Hospital, Wuhan University, China: mucinous cystadenoma of the renal pelvis	6
Improving informed consent in elective urological surgery using a digital consent platform	6
A systematic review on the outcomes of local anaesthetic transperineal prostate biopsy	6
Spontaneous (idiopathic) rupture of the urinary bladder: a systematic review of case series and reports	6
Is genetic testing coming of age in advanced prostate cancer?	6
Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration	6
Updates on bladder, kidney and prostate cancers	6
Journal information	6
New guidance regarding the diagnosis and risk stratification of patients with prostate cancer	6